— Know what they know.
Not Investment Advice
Also trades as: XYLO (NASDAQ) · $vol 0M

MDGS NASDAQ

Xylo Technologies Ltd.
1W: +19.1% 1M: -22.8% 3M: -37.9% 1Y: -70.8% 3Y: -91.5% 5Y: -94.9%
$2.36
Last traded 2024-05-13 — delisted
NASDAQ · Healthcare · Medical - Devices · $178.9M mcap · 26M float · 0.052% daily turnover

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$92M -0.1% ▼
5Y CAGR: +191.5%
Gross Profit
$12M -18.1% ▼
Operating Income
-$23M -69.2% ▼
Net Income
-$16M -57.0% ▼
EPS (Diluted)
$-380.00 -51.3% ▼
EBITDA
-$27M -127.5% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2019FY2020FY2021FY2022FY2023
Revenue$273K$531K$10M$92M$92M
YoY Growth-37.4%+94.5%+1805.5%+807.9%-0.1%
Cost of Revenue$455K$1M$5M$77M$80M
Gross Profit-$182K-$503K$5M$14M$12M
Gross Margin-66.7%-94.7%47.5%15.7%12.9%
R&D Expenses$609K$997K$1M$5M$6M
SG&A Expenses$14M$6M$12M$18M$17M
Operating Expenses$14M$7M$13M$23M$23M
Operating Income-$14M-$7M-$8M-$14M-$23M
Operating Margin-5282.1%-1390.6%-81.0%-15.0%-25.4%
Interest Expense$0$0$347K$2M$2M
Income Before Tax-$14M-$7M$4M-$10M-$22M
Tax Expense-$1K$9K$105K$111K-$74K
Net Income-$14M-$7M$4M-$10M-$16M
Net Margin-5193.4%-1290.0%40.0%-11.1%-17.5%
EPS (Diluted)$-108.80$-30.80$5.20$-251.20$-380.00
EBITDA-$14M-$8M-$22M-$12M-$27M
Shares Outstanding1302062224087678614064142153

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms